Search - tctmd.com

Displaying 1 - 20 of 158

Sort: Relevancy | Date

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TCT 980: The Impact of Residual Tricuspid Regurgitation on Long-term Clinical Outcomes, Following Tricuspid Transcatheter Edge-to-Edge Repair

Presenter: Patrascu Ionut Alexandru

October 29, 2024

Presentation TCT 2024

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

Presenter: Luis Rene Mata Quinonez

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 968: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Tricuspid Regurgitation: The Equitable Access Study III

Presenter: Sophie Offen

October 29, 2024

Presentation TCT 2024

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

Presenter: Mahesh Madhavan

October 29, 2024

Presentation TCT 2024

TCT 969: Clinical Outcomes of Patients Unsuitable for Transcatheter Tricuspid Valve Replacement

Presenter: Yuchao Guo

October 29, 2024

Presentation TCT 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presenter: Colin Barker

October 29, 2024

Presentation TCT 2024

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Presenter: Dilesha Kumanayaka

October 29, 2024

Presentation TCT 2024

Clinical Phenotypes of TR Patients: Same but Different?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Anatomy and Mechanisms of Tricuspid Regurgitation – What Keeps the Gates Open?

Presenter: Mark Reisman

October 29, 2024

Presentation TCT 2024

Between Pressure and Volume: Right Heart Physiology in TR

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Imaging Essentials for the Assessment of TR and Right Heart Function

Presenter: Mani Vannan

October 29, 2024

Presentation TCT 2024

Managing Patients With TR-Related Right Heart Failure and When Should We Intervene?

Presenter: Sean Pinney

October 29, 2024

Advertisement

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

TTVR Remains Safe, Effective in Presence of CIED Leads

What’s Going to Be Hot at TCT 2025

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

TCT 980: The Impact of Residual Tricuspid Regurgitation on Long-term Clinical Outcomes, Following Tricuspid Transcatheter Edge-to-Edge Repair

TCT 978: A Computational Modeling Strategy to Study Transcatheter Tricuspid Valve Replacements in Patients With Severe Tricuspid Regurgitation

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

TCT 968: Automatic Echocardiography Prompts Reveal Lack of Equitable Access to Care in Patients With Tricuspid Regurgitation: The Equitable Access Study III

TCT 967: Real World Outcomes of Patients With Severe Tricuspid Regurgitation Stratified by Clinical Sequelae

TCT 969: Clinical Outcomes of Patients Unsuitable for Transcatheter Tricuspid Valve Replacement

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

TCT 972: Short Term Outcomes of Transcatheter Tricuspid Valve Interventions on Post-Procedural Length of Hospital Stay, Readmission for HF and Procedure Success if an Intracardiac Device Is Present

Clinical Phenotypes of TR Patients: Same but Different?

Anatomy and Mechanisms of Tricuspid Regurgitation – What Keeps the Gates Open?

Between Pressure and Volume: Right Heart Physiology in TR

Imaging Essentials for the Assessment of TR and Right Heart Function

Managing Patients With TR-Related Right Heart Failure and When Should We Intervene?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content